WEKO3
アイテム
{"_buckets": {"deposit": "3c441632-ec17-4129-8154-903fc3d4f79a"}, "_deposit": {"id": "44461", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "44461"}, "status": "published"}, "_oai": {"id": "oai:tsukuba.repo.nii.ac.jp:00044461", "sets": []}, "author_link": ["177905", "177906", "177907", "177908", "177909", "177910", "177911", "177912", "177913", "177914", "177915", "177916", "177917", "177918", "177919"], "item_1644910766877": {"attribute_name": "出版タイプ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_5_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2017-11", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "8", "bibliographicPageEnd": "2312", "bibliographicPageStart": "2304", "bibliographicVolumeNumber": "21", "bibliographic_titles": [{"bibliographic_title": "Cell Reports", "bibliographic_titleLang": "en"}]}]}, "item_5_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "In the process of drug development, in vitro studies do not always adequately predict human-specific drug responsiveness in clinical trials. Here, we applied the advantage of human iPSC-derived neurons, which offer human-specific drug responsiveness, to screen and evaluate therapeutic candidates for Alzheimer’s disease (AD). Using AD patient neurons with nearly 100% purity from iPSCs, we established a robust and reproducible assay for amyloid β peptide (Aβ), a pathogenic molecule in AD, and screened a pharmaceutical compound library. We acquired 27 Aβ-lowering screen hits, prioritized hits by chemical structure-based clustering, and selected 6 leading compounds. Next, to maximize the anti-Aβ effect, we selected a synergistic combination of bromocriptine, cromolyn, and topiramate as an anti-Aβ cocktail. Finally, using neurons from familial and sporadic AD patients, we found that the cocktail showed a significant and potent anti-Aβ effect on patient cells. This human iPSC-based platform promises to be useful for AD drug development.", "subitem_description_language": "en", "subitem_description_type": "Abstract"}]}, "item_5_publisher_27": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "Cell Press", "subitem_publisher_language": "en"}]}, "item_5_relation_10": {"attribute_name": "PubMed番号", "attribute_value_mlt": [{"subitem_relation_type_id": {"subitem_relation_type_id_text": "29166618", "subitem_relation_type_select": "PMID"}}]}, "item_5_relation_11": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type": "isIdenticalTo", "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://doi.org/10.1016/j.celrep.2017.10.109", "subitem_relation_type_select": "DOI"}}]}, "item_5_rights_12": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "(c) 2017 The Author(s). ", "subitem_rights_language": "en"}, {"subitem_rights": "This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).", "subitem_rights_language": "en"}]}, "item_5_source_id_7": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "2211-1247", "subitem_source_identifier_type": "PISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "open access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_abf2"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Kondo, Takayuki", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "177905", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Imamura, Keiko", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "177906", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Funayama, Misato", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "177907", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tsukita, Kayoko", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "177908", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Miyake, Michiyo", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "177909", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ohta, Akira", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "177910", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Woltjen, Knut", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "177911", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nakagawa, Masato", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "177912", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Asada, Takashi", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "177913", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Arai, Tetsuaki", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "177914", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kawakatsu, Shinobu", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "177915", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Izumi, Yuishin", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "177916", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kaji, Ryuji", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "177917", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Iwata, Nobuhisa", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "177918", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Inoue, Haruhisa", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "177919", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2017-12-15"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "CR_21-8.pdf", "filesize": [{"value": "7.8 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_5", "mimetype": "application/pdf", "size": 7800000.0, "url": {"label": "CR_21-8", "objectType": "fulltext", "url": "https://tsukuba.repo.nii.ac.jp/record/44461/files/CR_21-8.pdf"}, "version_id": "c6bc3fdb-fe9c-4db6-9cf0-a01d45de9f87"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer’s Disease", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer’s Disease", "subitem_title_language": "en"}]}, "item_type_id": "5", "owner": "1", "path": ["1498", "5294"], "permalink_uri": "http://hdl.handle.net/2241/00149338", "pubdate": {"attribute_name": "PubDate", "attribute_value": "2017-12-15"}, "publish_date": "2017-12-15", "publish_status": "0", "recid": "44461", "relation": {}, "relation_version_is_last": true, "title": ["iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer’s Disease"], "weko_shared_id": -1}
iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer’s Disease
http://hdl.handle.net/2241/00149338
http://hdl.handle.net/2241/00149338ff30d3e5-e88c-4791-b156-b1e1cf981270
名前 / ファイル | ライセンス | アクション |
---|---|---|
CR_21-8 (7.8 MB)
|
Item type | Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2017-12-15 | |||||
タイトル | ||||||
言語 | en | |||||
タイトル | iPSC-Based Compound Screening and In Vitro Trials Identify a Synergistic Anti-amyloid β Combination for Alzheimer’s Disease | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源 | http://purl.org/coar/resource_type/c_6501 | |||||
タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | open access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_abf2 | |||||
著者 |
Kondo, Takayuki
× Kondo, Takayuki× Imamura, Keiko× Funayama, Misato× Tsukita, Kayoko× Miyake, Michiyo× Ohta, Akira× Woltjen, Knut× Nakagawa, Masato× Asada, Takashi× Arai, Tetsuaki× Kawakatsu, Shinobu× Izumi, Yuishin× Kaji, Ryuji× Iwata, Nobuhisa× Inoue, Haruhisa |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | In the process of drug development, in vitro studies do not always adequately predict human-specific drug responsiveness in clinical trials. Here, we applied the advantage of human iPSC-derived neurons, which offer human-specific drug responsiveness, to screen and evaluate therapeutic candidates for Alzheimer’s disease (AD). Using AD patient neurons with nearly 100% purity from iPSCs, we established a robust and reproducible assay for amyloid β peptide (Aβ), a pathogenic molecule in AD, and screened a pharmaceutical compound library. We acquired 27 Aβ-lowering screen hits, prioritized hits by chemical structure-based clustering, and selected 6 leading compounds. Next, to maximize the anti-Aβ effect, we selected a synergistic combination of bromocriptine, cromolyn, and topiramate as an anti-Aβ cocktail. Finally, using neurons from familial and sporadic AD patients, we found that the cocktail showed a significant and potent anti-Aβ effect on patient cells. This human iPSC-based platform promises to be useful for AD drug development. | |||||
言語 | en | |||||
書誌情報 |
en : Cell Reports 巻 21, 号 8, p. 2304-2312, 発行日 2017-11 |
|||||
ISSN | ||||||
収録物識別子タイプ | PISSN | |||||
収録物識別子 | 2211-1247 | |||||
PubMed番号 | ||||||
識別子タイプ | PMID | |||||
関連識別子 | 29166618 | |||||
DOI | ||||||
関連タイプ | isIdenticalTo | |||||
識別子タイプ | DOI | |||||
関連識別子 | https://doi.org/10.1016/j.celrep.2017.10.109 | |||||
権利 | ||||||
言語 | en | |||||
権利情報 | (c) 2017 The Author(s). | |||||
権利 | ||||||
言語 | en | |||||
権利情報 | This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). | |||||
出版タイプ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
出版者 | ||||||
言語 | en | |||||
出版者 | Cell Press |